32nd treatment shown to reduce risk in
February 2022
No treatment is 100% effective. Protocols
combine complementary and synergistic treatments. * >10%
efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for
60+ treatments. c19early.org
|
|
relative SHOKS-COVID score, 11.3% better, RR 0.89, p = 0.47, treatment mean 2.12 (±1.39) n=33, control mean 2.39 (±1.59) n=33.
|
|
risk of PCR+ on day 10 or hospitalization >10 days, 38.8% lower, RR 0.61, p = 0.02, treatment 14 of 24 (58.3%), control 20 of 21 (95.2%), NNT 2.7, odds ratio converted to relative risk.
|
|
hospitalization time, 8.2% lower, relative time 0.92, p = 0.35, treatment 33, control 33.
|
|
risk of no viral clearance, 87.4% lower, RR 0.13, p = 0.08, treatment 0 of 17 (0.0%), control 3 of 13 (23.1%), NNT 4.3, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 10.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
